Erganeo invest in the future with the European Sustainable Development Week 2023

14 September 2023

The European Sustainable Development Week (ESDW) represents an initiative aimed at actively promoting sustainable development and the Sustainable Development Goals (SDGs) throughout Europe. In 2022, the ESDW reached a historic milestone by listing over 7,000 projects at the European level, marking a first in the history of the ESDW. Initiated by France in 2003, the Sustainable Development Week aims to raise public awareness about the 17 Sustainable Development Goals (SDGs) of the 2030 Agenda. It also encourages concrete engagement at all levels, whether individual or collective, by promoting initiatives in favor of sustainable development.

As an actor committed to innovation and sustainable development, Erganeo holds a strong commitment to addressing current societal and environmental challenges. We support numerous technologies that align with various Sustainable Development Goals (SDGs), as was the case once again this year, notably with:

ODD 3 – GOOD HEALTH AND WELL-BEING

MethysDX

An exclusive license has been signed between Erganeo and METHYS Dx for the exploitation of diagnostic biomarkers through liquid biopsy. The startup aims to initiate a first clinical trial shortly with a market release of kits estimated for 2026.

Read the article

Persea

In late 2022, an exclusive license was signed between Erganeo and the start-up Persea for the development of a new liver cancer treatment. This innovative approach combines suicide gene methods and cell therapy, based on a therapeutic strategy called BioTrojan, referencing the “Trojan Horse.”

Read the article

Imisca

The start-up Imisca and Erganeo have signed an exclusive license for the exploitation of a new gelling solution to reduce the recurrence rate after local treatment of colorectal cancers, improve patient survival, and optimize their treatments.

Read the article

EVerZom

In June 2023, Summit Pharmaceuticals International and the start-up EVerZom entered into an exclusive distribution agreement in Japan. The Japanese company, specializing in the bioproduction of extracellular vesicles, enables EVerZom to ensure high-quality monitoring and research and development support across various domains.

Read the article

IPCure

In April 2023, the start-up IPCure and Erganeo signed a license for the exclusive exploitation of a new family of compounds for the treatment of certain inflammatory diseases.

Read the article

Augmented Endoscopy

Following the signing of a research collaboration agreement with APHP, start-up Augmented Endoscopy and Erganeo entered into an exclusive license agreement in March 2023 to exploit the Axaro.ai solution. This artificial intelligence platform is designed for fast and reliable detection, analysis, and diagnosis of digestive tract diseases.

Read the article

Z-Score

The Z-Score technology, developed with the support of Erganeo, is a tool designed for the automatic detection of abnormal and pathological values during the monitoring of urinary and blood parameters.

Learn more about Z-Score

Dextrain

The start-up offers a manual dexterity tool with machine learning capabilities as part of rehabilitation following a stroke or for early detection of neurological diseases. In November 2022, Dextrain received the BPI Deep Tech label and the French Tech Emergence Grant (BFTE) to support its innovation project based on academic research. In July 2023, the results of the latest clinical trials were published in the Journal of NeuroEngineering and Rehabilitation (JNR).

Learn more about Dextrain

AbilyCare

In early September, the start-up joined Bpifrance’s “Les Deeptechs – À Fonds” support program, representing a significant opportunity for the company. The start-up is developing a gait and balance assessment test aimed at preventing risks across all age groups.

Learn more about AbilyCare

Daytot

Since October 2022, the Daytot brand has been on the market. It was created with the aim of deploying an innovative early intervention device designed to assist newborns in crawling.

Read the article

ODD 11 – SUSTAINABLE TOWNS AND COMMUNITIES

Safely Synthesizing Nanocrystals without Dissemination Risk

New Synthesis of Antibacterial TiO2 Nanoparticles Active in Photocatalysis for Air Treatment and Filtration on Various Surfaces.

Discovering the technology

Régénération du charbon actif et de la dégradation des polluants organiques

Les fibres de carbone actifs permettent une absorption rapide des polluants organiques et sont utilisées comme cathode pendant le processus de régénération.

Découvrir la technologie

ODD 12 – RESPONSIBLE CONSUMPTION AND PRODUCTION

Auressens

Winner of the i-Lab 2023 competition, Auressens has developed a technology capable of producing coatings that have the reflective appearance of metal while being composed exclusively of organic matter. These coatings derive their colour and optical properties from dyes belonging to innovative families of molecules, offering a variety of optical effects depending on their composition, all in a cost-effective and environmentally-friendly way.

Learn more about Auressens

ODD 15 – TERRESTRIAL LIFE

Micro Fine Particle Analyzer

Miniature MEMS Sensor for Real-Time Detection of Fine Particles in Indoor and Outdoor Air.

Discovering the technology

Air and Water Pollution Remediation in Civil Engineering

ZnO Nanocrystals Grown on Civil Engineering Infrastructure Surfaces for Photocatalysis-Based Treatment of Air and Water Pollutants.

Discovering the technology

Suivez-nous

Inscrivez-vous à notre Newsletter pour ne rien manquer de nos actualités

Related content